81 related articles for article (PubMed ID: 6264540)
1. [Influencing of the rate of taking root of the tumor by L-dopa, amantadine and measles vaccine in combination with gamma radiation (author's transl)].
Busse E; Rose H; Helmholz M; Krüger B
Radiobiol Radiother (Berl); 1980; 21(6):788-93. PubMed ID: 6264540
[No Abstract] [Full Text] [Related]
2. [Effect of the cAMP and interferon levels in the lymphocytes and on a change in the tumor growth rate of a transplantable golden hamster melanoma after BCG, measles vaccine, L-DOPA and amantadine treatment].
Busse E; Rose H; Riessbeck KH
Radiobiol Radiother (Berl); 1980; 21(3):292-301. PubMed ID: 6161389
[No Abstract] [Full Text] [Related]
3. [On the therapy of mamma carcinoma of C3H mice by means of thymic factor, measles vaccine and L-dopa (author's transl)].
Busse E; Rose H; Helmholz M
Radiobiol Radiother (Berl); 1981; 22(1):63-8. PubMed ID: 7232709
[No Abstract] [Full Text] [Related]
4. [Modern antiparkinsonics (L-dopa and amantadine) and presentday psychiatry (author's transl)].
Dolezalová B; Vacek J
Cesk Psychiatr; 1976 Dec; 72(6):403-7. PubMed ID: 1000706
[No Abstract] [Full Text] [Related]
5. [Comparison between the effects of L-dopa, prodipine and amantadine on the serum and CSF amino acid levels in Parkinson's disease (author's transl)].
Gründig E; Gerstenbrand F
Wien Klin Wochenschr; 1980 Dec; 92(24):868-71. PubMed ID: 7222702
[TBL] [Abstract][Full Text] [Related]
6. [Changes of leukocyte and lymphocyte values and of cytotoxicity in tumour-carrying rats in dependence on a local irradiation and increase of cAMP level, respectively (author's transl)].
Rose H; Busse E
Radiobiol Radiother (Berl); 1981; 22(3):331-5. PubMed ID: 6272348
[No Abstract] [Full Text] [Related]
7. [The additive effect of amantadine hydrochloride (Symmetrel) on parkinsonian patients receiving levodopa treatment (author's transl)].
Shiozawa R; Kase M; Kuroiwa Y; Narabayashi H; Nishitani Y; Ohmoto T; Toyokura Y; Uono K
No To Shinkei; 1981 Mar; 33(3):301-9. PubMed ID: 7018522
[No Abstract] [Full Text] [Related]
8. [The influence of L-dopa and of thymus fraction on the survival rate of whole-body-irradiated mice].
Busse E; Helmholz M
Arch Geschwulstforsch; 1982; 52(4):253-7. PubMed ID: 6753789
[TBL] [Abstract][Full Text] [Related]
9. Levetiracetam potentiates the antidyskinetic action of amantadine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease.
Hill MP; Ravenscroft P; Bezard E; Crossman AR; Brotchie JM; Michel A; Grimée R; Klitgaard H
J Pharmacol Exp Ther; 2004 Jul; 310(1):386-94. PubMed ID: 15004218
[TBL] [Abstract][Full Text] [Related]
10. [L-dopa-induced movement disorders in Parkinson disease. Amantadine improves dyskinesia].
MMW Fortschr Med; 2001 May; 143 Suppl 2():93. PubMed ID: 11434272
[No Abstract] [Full Text] [Related]
11. Twenty-five years of amantadine therapy in Parkinson's disease.
Danielczyk W
J Neural Transm Suppl; 1995; 46():399-405. PubMed ID: 8821075
[TBL] [Abstract][Full Text] [Related]
12. [Preclinical conception and clinical uses of L-dopa in combination with tricyclic antidepressives in pharmacoresistant depressions (author's transl)].
Kabes J; Pöschlová N; Krsiak M; Dostal T; Masek K; Volsan O
Cesk Psychiatr; 1976 Oct; 72(5):324-31. PubMed ID: 1000695
[No Abstract] [Full Text] [Related]
13. Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms.
Giorgi M; D'Angelo V; Esposito Z; Nuccetelli V; Sorge R; Martorana A; Stefani A; Bernardi G; Sancesario G
Eur J Neurosci; 2008 Sep; 28(5):941-50. PubMed ID: 18717735
[TBL] [Abstract][Full Text] [Related]
14. [Changes in cerebrospinal fluid and plasma cyclic nucleotides following amygdaloid kindling and kindled convulsions in cats (author's transl)].
Akiyama T
Seishin Shinkeigaku Zasshi; 1981; 83(7):418-29. PubMed ID: 6276909
[No Abstract] [Full Text] [Related]
15. A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease.
Johnston TH; Lee J; Gomez-Ramirez J; Fox SH; Brotchie JM
Exp Neurol; 2005 Feb; 191(2):243-50. PubMed ID: 15649479
[TBL] [Abstract][Full Text] [Related]
16. Induction of dopamine biosynthesis by l-DOPA in PC12 cells: implications of L-DOPA influx and cyclic AMP.
Jin CM; Yang YJ; Huang HS; Lim SC; Kai M; Lee MK
Eur J Pharmacol; 2008 Sep; 591(1-3):88-95. PubMed ID: 18602388
[TBL] [Abstract][Full Text] [Related]
17. [Antiparkinsonian drugs (author's transl)].
Ando K
No To Shinkei; 1980 Aug; 32(8):743-53. PubMed ID: 7008813
[No Abstract] [Full Text] [Related]
18. Interactions between a novel cholinergic ion channel agonist, SIB-1765F and L-DOPA in the reserpine model of Parkinson's disease in rats.
Menzaghi F; Whelan KT; Risbrough VB; Rao TS; Lloyd GK
J Pharmacol Exp Ther; 1997 Jan; 280(1):393-401. PubMed ID: 8996220
[TBL] [Abstract][Full Text] [Related]
19. [Short-term induced hyperglycemia in the radiotherapy of experimental tumors].
Vepkhvadze NR
Med Radiol (Mosk); 1983 Jul; 28(7):54-5. PubMed ID: 6877061
[No Abstract] [Full Text] [Related]
20. [Combined drug and radiation therapy of IMR-1 sarcoma with regard to its mitotic activity].
Kharlampovich SI
Vopr Onkol; 1970; 16(1):75-82. PubMed ID: 5434579
[No Abstract] [Full Text] [Related]
[Next] [New Search]
